Navigation Links
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Date:2/23/2009

BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as of February 18, 2009. As a result of Dr. Dhingra's appointment, the Board is now comprised of nine members.

Dr. Dhingra has been active in oncology clinical research for over 20 years. During his tenure at Hoffmann-La Roche from 1999 to 2008, he built the largest oncology clinical development department in the industry. Dr. Dhingra provided strategic development leadership resulting in a successful track record of global oncology drug approvals, including numerous indications for Herceptin(R), MabThera(R), Xeloda(R), Bondronat(R), Tarceva(R) and Avastin(R). In his academic career, Dr. Dhingra received several research grants from the National Cancer Institute as well as from major oncology pharmaceutical and biotechnology companies and built an impressive record of publications in peer-reviewed journals.

"We are honored to have Dr. Dhingra join the Board of Directors," said David F. Hale, Chairman of the Board of Micromet. "His significant success and proven track record in the development of oncology drugs will be a tremendous asset to Micromet as we advance our clinical stage product candidates to pivotal trials."

"Micromet's BiTE antibodies have the potential to become the next big breakthrough in cancer therapy. Having taken part in the successful development of the first generation of therapeutic antibodies for the treatment of various cancers, I look forward to working with the board and management of Micromet and contributing to the development of its BiTE antibodies and other clinical stage product candidates.
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...d LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/...tin Board: CYXN; ,China Yongxin,Pharmaceuticals, o...tor and,retailer of pharmaceuticals in Northeaster...ion for distribution of medicines on the Essential...ntly formalized the nation,s Essential Drug,List w...
(Date:11/30/2009)...r in providing smart and efficient software to the...®, evolutionizing work-from-home histopatholog...; software used by 8 of the Top 10 Pharmaceutical ...lide’ basis. , Moun...as announced another evolution in the histopatholo...
(Date:11/30/2009)... /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ...dical-device research and,development outsourcing ...ates,announced that it had been selected to the D... fifth consecutive year. The list recognizes the 5... media, and telecommunications,industries based on...
(Date:11/29/2009)...n . , The concept of confinement is one of t...s example is that of quarks which bind together to...rom Helmholtz-Zentrum Berlin together with an inte...time an experimental realization and a proof of co...r system. , The concept of confinement states th...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Spinons -- confined like quarks 2
...Drug,Delivery: Emerging Modes, Novel Science and P...for October 29-30, 2007, at the Flamingo in Las,Ve...in controlled release,technologies, nanobiomedicin...g delivery, tumor targeting and other novel applic...ther systemic drug absorption,platforms. The prog...
...e "Company") (Nasdaq: VRML ) announced today that...Stock Market ("Nasdaq") that the Company has,regai...)(3) as a result of,achieving a market value of li...35 million or more for a period of 10 consecutive ...st 17, 2007 that the Company was not in,compliance...
...SPeRATE Hypertension Treatment Device ..., Sept. 17 InterCure, Ltd. (TASE:,INCR), today an...nt device,clinically-proven in 10 peer-reviewed st...launch into retail distribution in the United King...stributor of healthcare,diagnostics to the indepen...
Other Biology Technology:Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 2Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 3Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 3InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 4
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
(Date:11/24/2009)... may help gut bacteria bind to the gastrointestina...oducers to identify strains that are likely to be ...interact with cells lining the gut to have a benef...e gut they are more likely to stick around long en...ge from the Institute of Food Research. IFR is an...
(Date:11/24/2009)...rets of the earth,s history locked in its icy dept... information on the environments that have been se...ow, a team of researchers from nine institutions ... million dollars by the National Science Foundatio...ly. These scientists will drill through the West A...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 1GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 3FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 1FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 2FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 3Diabetes Medications Dont Lower Inflammation 57271 1Diabetes Medications Dont Lower Inflammation 57271 2Diabetes Medications Dont Lower Inflammation 57271 3
...sociation for Cancer Research extends its sincere ...nomination to lead the Food and Drug Administratio...see the advancement of cutting-edge products and t...vention of cancer. Her leadership will bring new p...devising regulatory pathways for biomarker approva...
...roviral therapy) has emerged as an extremely effec...undetectable; however, HAART can never truly eradi...in cells. But, a chemical called suberoylanilide h...emia drug, has now been shown to ,turn on, latent ... the hidden virus that HAART misses. , Matija Pe...
...ygen atoms dancing on a metal oxide slab, glowing ...ts better understand how water splits into oxygen ...visualized a chemical reaction that had previously... understanding of the chemistry needed to generate... water. , The scientists made the discovery while...
Other Biology News:Dancing 'adatoms' help chemists understand how water molecules split 2Dancing 'adatoms' help chemists understand how water molecules split 3
PCR Optimization Kit; Kit for optimization of PCR from Roche Applied Science
...cans MiniPrep series of robotic workstations is de...iniPrep is the ideal automation platform for routi...e laboratory procedures, improving throughput, pro...ini for MiniPrep software allows you to control th...
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
FluoroGuard Antifade Reagent from Bio-Rad
Biology Products: